---
title: "H&H Delivers Strong Q1 Revenue Growth on China-Driven Nutrition Demand and Deleveraging"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283636437.md"
description: "Health and Happiness (H&H) International Holdings reported a 34.4% year-on-year revenue increase in Q1 2026, reaching RMB4.26 billion, driven by strong demand for nutritional supplements, particularly in China. The Baby Nutrition and Care segment saw a 60.9% rise, with infant formula sales surging 74.4%. The company also reduced gross debt by over RMB300 million, enhancing its financial flexibility. Analysts rate the stock as a Buy with a target price of HK$15.80."
datetime: "2026-04-22T09:42:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283636437.md)
  - [en](https://longbridge.com/en/news/283636437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283636437.md)
---

# H&H Delivers Strong Q1 Revenue Growth on China-Driven Nutrition Demand and Deleveraging

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Health and Happiness (H&H) International Holdings ( (HK:1112) ) has issued an update.

Health and Happiness (H&H) International Holdings reported a 34.4% year-on-year rise in first-quarter 2026 revenue to RMB4.26 billion, with high-margin nutritional supplements contributing nearly 60% of sales. Growth was broad-based across adult, baby and pet segments, aided by Chinese New Year seasonality and stronger demand for Biostime infant milk formulas in mainland China.

The Baby Nutrition and Care business led performance with a 60.9% increase, including a 74.4% surge in infant formula sales in China, while Adult Nutrition and Care grew 26.3% and Pet Nutrition and Care achieved modest gains but faster growth in premium pet supplements such as Zesty Paws. The group also continued to deleverage, cutting gross debt by over RMB300 million by voluntarily prepaying more than RMB500 million of its U.S. dollar term loan, supported by stronger internal liquidity and cheaper renminbi borrowing, which strengthens its balance sheet and financial flexibility.

The most recent analyst rating on (HK:1112) stock is a Buy with a HK$15.80 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.

**More about Health and Happiness (H&H) International Holdings**

Health and Happiness (H&H) International Holdings is a Hong Kong–listed health and wellness company focused on baby nutrition and care, adult nutrition and care, and pet nutrition and care. Its portfolio includes infant milk formula, paediatric probiotics, vitamins and supplements, and premium pet supplements, with significant exposure to the Chinese mainland, Australia-New Zealand and selected expansion markets.

**Average Trading Volume:** 2,015,862

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$8.83B

For a thorough assessment of 1112 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [01112.HK](https://longbridge.com/en/quote/01112.HK.md)

## Related News & Research

- [CLSA Reaffirms Their Buy Rating on Health and Happiness (H&H) International Holdings (BTSDF)](https://longbridge.com/en/news/283611622.md)
- [22:19 ETGROWNSY Debuted an Exciting New Line of Innovative Baby Care Products at ABC Kids Expo 2026](https://longbridge.com/en/news/286992206.md)
- [12:05 ETUPPAbaby Unveils Kona: A Stroller Built for How Modern Parents Actually Move](https://longbridge.com/en/news/286290814.md)
- [13:39 ETRodeo Dental & Orthodontics Expands Access to Affordable, Quality Dental Care in Glendale](https://longbridge.com/en/news/286804016.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)